Kronos Bio, a San Mateo biotech company, is losing millions of dollars a month and recently had to discontinue its sole clinical-stage compound because of adverse side effects. Now, the company is ...

Kronos Bio has announced the appointment of Deborah Knobelman as president and interim chief executive officer, effective from 3 December 2024. Dr Knobelman will also become principal executive and ...

The latest update is out from Kronos Bio ( (KRON)). Kronos Bio, Inc. is undergoing a significant transformation with an 83% workforce reduction aimed at strategic cost containment by December 31, 2024 ...

On the heels Kronos Bio’s decision to can its last remaining clinical asset earlier this month, the company said it would roll out “significant expense reduction strategies” to buy itself more time.

Kronos Bio, Inc. (NASDAQ:KRON) shares are trading higher on Wednesday in the premarket session. The firm announced significant leadership and operational changes. Deborah Knobelman has been appointed ...

Kronos Bio has made its second round of layoffs in five months, with another fifth of the biotech’s workforce heading to the exits as the company focuses on a CDK9 inhibitor. Laying off 21% of staff ...

Kronos Bio (NASDAQ:KRON) said it was laying off 21% of its workforce as part of a restructuring effort that will extend its cash runway into the second half of 2026. The company intends to focus its ...

On Dec. 11, 2021, Kronos, a workforce management company that services over 40 million people in over 100 countries, received a rude awakening when it realized its Kronos Private Cloud was compromised ...

Ultimate Kronos Group, one of the largest human resources companies, disclosed a crippling ransomware attack on Monday, impacting payroll systems for a number of workers. After noticing “unusual ...